Febuxostat - Latest Advances

Reply to "Febuxostat use is associated with a significantly greater risk of mild to moderate perturbation of liver function compared to benzbromarone in patients with gout: comment on the article by Sun et al".

Journal: Arthritis care & research

Published: September 23, 2025

Uric Acid-Lowering Therapy with Febuxostat in Patients with Chronic Heart Failure and Hyperuricemia: A Prospective and Observational Cohort Study.

Journal: Balkan medical journal

Published: September 22, 2025

Outcomes in Patients With Tumor Lysis Syndrome and Comorbid Gout: A Propensity-Matched Study From a Global Federated Health Research Network.

Journal: Cureus

Published: September 15, 2025

Risk of Hepatotoxicity in Patients With Gout Treated With Febuxostat or Benzbromarone: comment on article by Sun W et al.

Journal: Arthritis care & research

Published: September 09, 2025

Febuxostat-induced hepatocellular injury.

Journal: BMJ case reports

Published: August 31, 2025

Spinal Gout Diagnosed by Dual-Energy CT: A Case Report of Prior Misdiagnosis.

Journal: Cureus

Published: August 18, 2025

Febuxostat-aloperine co-amorphous drug delivery system with enhanced water solubility and binding affinity to xanthine oxidase.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: August 07, 2025

Clinical characteristics and treatment of two children with Lesch-Nyhan syndrome

Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics

Published: August 05, 2025

Anticolitis effect of febuxostat. The imperative role of NLRP-3/Caspase-1/IL-1β pathway via histopathological, immunohistochemical and biochemical approach.

Journal: Immunopharmacology and immunotoxicology

Published: August 04, 2025

Impact of Urate-Lowering Agents on Renal Outcomes in Chronic Kidney Disease: A Systematic Review.

Journal: Cureus

Published: August 04, 2025

Comparison of Clinical Characteristics in Older-Onset and Common-Age-of-Onset Gout: A Prospective Gout Cohort Study.

Journal: Drugs & aging

Published: July 24, 2025

Shenling Baizhu San attenuates testicular spermatogenic dysfunction in hyperuricemic mice via dual modulation of MAPK/NF-κB and NLRP3 inflammasome pathways.

Journal: Hereditas

Published: July 17, 2025

Filters

Reply to "Febuxostat use is associated with a significantly greater risk of mild to moderate perturbation of liver function compared to benzbromarone in patients with gout: comment on the article by Sun et al".

Reply to "Febuxostat use is associated with a significantly greater risk of mild to moderate perturbation of liver function compared to benzbromarone in patients with gout: comment on the article by Sun et al".

Uric Acid-Lowering Therapy with Febuxostat in Patients with Chronic Heart Failure and Hyperuricemia: A Prospective and Observational Cohort Study.

Uric Acid-Lowering Therapy with Febuxostat in Patients with Chronic Heart Failure and Hyperuricemia: A Prospective and Observational Cohort Study.

Outcomes in Patients With Tumor Lysis Syndrome and Comorbid Gout: A Propensity-Matched Study From a Global Federated Health Research Network.

Outcomes in Patients With Tumor Lysis Syndrome and Comorbid Gout: A Propensity-Matched Study From a Global Federated Health Research Network.

Risk of Hepatotoxicity in Patients With Gout Treated With Febuxostat or Benzbromarone: comment on article by Sun W et al.

Risk of Hepatotoxicity in Patients With Gout Treated With Febuxostat or Benzbromarone: comment on article by Sun W et al.

Febuxostat-induced hepatocellular injury.

Febuxostat-induced hepatocellular injury.

Spinal Gout Diagnosed by Dual-Energy CT: A Case Report of Prior Misdiagnosis.

Spinal Gout Diagnosed by Dual-Energy CT: A Case Report of Prior Misdiagnosis.

Febuxostat-aloperine co-amorphous drug delivery system with enhanced water solubility and binding affinity to xanthine oxidase.

Febuxostat-aloperine co-amorphous drug delivery system with enhanced water solubility and binding affinity to xanthine oxidase.

Clinical characteristics and treatment of two children with Lesch-Nyhan syndrome

Clinical characteristics and treatment of two children with Lesch-Nyhan syndrome

Anticolitis effect of febuxostat. The imperative role of NLRP-3/Caspase-1/IL-1β pathway via histopathological, immunohistochemical and biochemical approach.

Anticolitis effect of febuxostat. The imperative role of NLRP-3/Caspase-1/IL-1β pathway via histopathological, immunohistochemical and biochemical approach.

Impact of Urate-Lowering Agents on Renal Outcomes in Chronic Kidney Disease: A Systematic Review.

Impact of Urate-Lowering Agents on Renal Outcomes in Chronic Kidney Disease: A Systematic Review.

Comparison of Clinical Characteristics in Older-Onset and Common-Age-of-Onset Gout: A Prospective Gout Cohort Study.

Comparison of Clinical Characteristics in Older-Onset and Common-Age-of-Onset Gout: A Prospective Gout Cohort Study.

Shenling Baizhu San attenuates testicular spermatogenic dysfunction in hyperuricemic mice via dual modulation of MAPK/NF-κB and NLRP3 inflammasome pathways.

Shenling Baizhu San attenuates testicular spermatogenic dysfunction in hyperuricemic mice via dual modulation of MAPK/NF-κB and NLRP3 inflammasome pathways.